102 related articles for article (PubMed ID: 34918391)
1. Circulating JNK pathway-associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients.
Gao W; Gao L; Yang F; Li Z
J Clin Lab Anal; 2022 Jan; 36(1):e24153. PubMed ID: 34918391
[TBL] [Abstract][Full Text] [Related]
2. Increased serum IL‑41 associated with acute exacerbation of chronic obstructive pulmonary disease.
Cen T; Huang M; Li M; Jin J; Ding Q; Lv D; Fei L; Wang S; Ma H
Exp Ther Med; 2024 Aug; 28(2):312. PubMed ID: 38873046
[TBL] [Abstract][Full Text] [Related]
3. Associations of the Serum KL-6 with Severity and Prognosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Wang Y; Fei J; Xu J; Cheng ZY; Ma YC; Wu JH; Yang J; Zhao H; Fu L
Lung; 2024 Jun; 202(3):245-255. PubMed ID: 38743087
[TBL] [Abstract][Full Text] [Related]
4. JNK Pathway-Associated Phosphatase Deficiency Facilitates Atherosclerotic Progression by Inducing T-Helper 1 and 17 Polarization and Inflammation in an ERK- and NF-κB Pathway-Dependent Manner.
Chen X; Fang M; Hong J; Guo Y
J Atheroscler Thromb; 2024 May; ():. PubMed ID: 38797677
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal microRNA-1258 may as a novel biomarker for the diagnosis of acute exacerbations of chronic obstructive pulmonary disease.
Wang F; Yang B; Qiao J; Bai L; Li Z; Sun W; Liu Q; Yang S; Cui L
Sci Rep; 2023 Oct; 13(1):18332. PubMed ID: 37884583
[TBL] [Abstract][Full Text] [Related]
6. Association of Serum Galectin-3 with the Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Feng W; Wu X; Li S; Zhai C; Wang J; Shi W; Li M
Med Sci Monit; 2017 Sep; 23():4612-4618. PubMed ID: 28947730
[TBL] [Abstract][Full Text] [Related]
7. The Diagnostic and Assessment Value of Plasma Pentraxin 3 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Gu Y; Li P; Xiao Y; Zhang J; Su X
Int J Chron Obstruct Pulmon Dis; 2023; 18():1391-1400. PubMed ID: 37456914
[TBL] [Abstract][Full Text] [Related]
8. Correlation of Coagulation Dysfunction with Infection and Hypercapnia in Acute Exacerbation of COPD Patients.
Zheng LL; Wang S; Li ZG; Han L; Zhu CD; Li CY; Zhang XX; Deng X
Infect Drug Resist; 2023; 16():5387-5394. PubMed ID: 37614682
[TBL] [Abstract][Full Text] [Related]
9. Plasma sCD146 is a potential biomarker for acute exacerbation of chronic obstructive pulmonary disease.
Jia X; Jiang J; Yang C; Zhang S; Wu J; Ma Q; Wang Z; Chen Z; Zhang M; Huang M; Ji N
Clin Transl Sci; 2024 Mar; 17(3):e13754. PubMed ID: 38476031
[TBL] [Abstract][Full Text] [Related]
10. Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease: a preliminary study.
Wu X; Sun X; Chen C; Bai C; Wang X
Crit Care; 2014 Nov; 18(6):508. PubMed ID: 25407108
[TBL] [Abstract][Full Text] [Related]
11. Preventing CXCL12 elevation helps to reduce acute exacerbation of COPD in individuals co-existing type-2 diabetes: A bioinformatics and clinical pharmacology study.
Xue H; Chen Q; Lan X; Xu H; Yang H; Lin C; Xue Q; Xie B
Int Immunopharmacol; 2024 May; 132():111894. PubMed ID: 38569426
[TBL] [Abstract][Full Text] [Related]
12. Physical status, symptoms and health-related quality of life during a severe exacerbation of COPD: Recovery and discriminative capacity for future events.
Quadflieg K; Machado A; de Lima FF; Dederen A; Daenen M; Ruttens D; Thomeer M; Spruit MA; Burtin C
Respir Med; 2023 Dec; 220():107437. PubMed ID: 37918543
[TBL] [Abstract][Full Text] [Related]
13. COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.
Leung JM; Chen V; Hollander Z; Dai D; Tebbutt SJ; Aaron SD; Vandemheen KL; Rennard SI; FitzGerald JM; Woodruff PG; Lazarus SC; Connett JE; Coxson HO; Miller B; Borchers C; McManus BM; Ng RT; Sin DD
PLoS One; 2016; 11(8):e0161129. PubMed ID: 27525416
[TBL] [Abstract][Full Text] [Related]
14. Serum JKAP reflects Th2 and Th17 cell levels, and diabetic nephropathy risk and severity in diabetes mellitus patients.
Tong M; Gu C; Yu Q; Ma J
Biomark Med; 2023 Sep; 17(17):701-710. PubMed ID: 38179996
[No Abstract] [Full Text] [Related]
15. Association of Frailty with Patient-Report Outcomes and Major Clinical Determinants in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Yang M; Liu Y; Zhao Y; Wang Z; He J; Wang Y; Anme T
Int J Chron Obstruct Pulmon Dis; 2024; 19():907-919. PubMed ID: 38628984
[TBL] [Abstract][Full Text] [Related]
16. A Novel Metabolic Score for Predicting the Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
Peng L; You H; Xu MY; Dong ZY; Liu M; Jin WJ; Zhou C
Int J Chron Obstruct Pulmon Dis; 2023; 18():785-795. PubMed ID: 37180750
[TBL] [Abstract][Full Text] [Related]
17. The association between cystatin C and COPD: a meta-analysis and systematic review.
Chai L; Feng W; Zhai C; Shi W; Wang J; Yan X; Wang Q; Zhang Q; Li M
BMC Pulm Med; 2020 Jun; 20(1):182. PubMed ID: 32586317
[TBL] [Abstract][Full Text] [Related]
18. N-Acetylcysteine Improves Inflammatory Response in COPD Patients by Regulating Th17/Treg Balance through Hypoxia Inducible Factor-1
Liu X; Hu Z; Zhou H
Biomed Res Int; 2021; 2021():6372128. PubMed ID: 34258270
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal changes of serum JKAP and IL-17A, and their linkage with anxiety, depression, and cognitive impairment in acute ischemic stroke patients.
Wang C; Huo H; Li J; Zhang W; Liu C; Jin B; Wang H; Zhao P
J Clin Lab Anal; 2022 Dec; 36(12):e24762. PubMed ID: 36397283
[TBL] [Abstract][Full Text] [Related]
20. Differences in plasma amino acid levels in patients with and without bacterial infection during the early stage of acute exacerbation of COPD.
Inoue S; Ikeda H
Int J Chron Obstruct Pulmon Dis; 2019; 14():575-583. PubMed ID: 30880947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
